ETNB 89bio, Inc.: institutional ownership and insider trading
5 funds reported holding $3.50M of 89bio, Inc. in their latest 13F filings; in Q1 2026 funds net bought $0, with 0 new positions and 2 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
Largest institutional holders of ETNB
- Nuveen Asset Management, LLC — $2.24M
- Point72 Asia (Singapore) Pte. Ltd. — $983K
- WOLVERINE TRADING, LLC — $209K
- Point72 (DIFC) Ltd — $58.6K
- Point72 Europe (London) LLP — $5.78K
Recent ETNB insider trades
- Jul 15, 2025: Le-Nguyen Quoc sold 10,461 shares ($115K)
- Apr 15, 2025: Le-Nguyen Quoc sold 15,329 shares ($91.2K)
- Jan 30, 2025: RA Capital Healthcare Fund LP bought 5,714,285 shares ($50.0M)
- Jan 22, 2025: McWherter Charles bought 15,000 shares ($99.9K)
5%+ owners
- The Vanguard Group: 5.6% (Schedule 13G, filed Jul 29, 2025)
- SUVRETTA CAPITAL MANAGEMENT, LLC: 5.6% (Schedule 13G/A, filed Nov 13, 2025)